Category Archives: People

Julian Barnes Named Laureate of the 2026 Fitzgerald Prize

British Novelist Honored at Hôtel Belles Rives for ‘Départ(s)’ at the Prize’s 15th Edition A Media Snippet accompanying this announcement is available by clicking on this link. JUAN-LES-PINS, France, June 12, 2026 (GLOBE NEWSWIRE) — The jury of the Fitzgerald Prize has announced British novelist Julian Barnes as the laureate of its 15th edition. The […]

Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company’s securities in a […]

Global Aerospace’s Annual Jetstream Publication Provides An Introduction to Litigation Funding

Litigation Funding: A Wolf in Sheep’s Clothing? Insights from Global Aerospace’s Annual Jetstream Publication Morris Plains, NJ, June 12, 2026 (GLOBE NEWSWIRE) — Imagine this scene: “And we, the jury, find in favour of the plaintiff in the amount of USD200 million.” Joy on the faces of the suits at the plaintiff’s bench. Utter disbelief […]

HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support

Horsewood 7-Herb Formula: Tongkat Ali 100:1, Horny Goat Weed, Saw Palmetto, Wild Yam, Nettle, Sarsaparilla, Boron Ingredients and Guarantee Largo, FL, June 12, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. Horsewood is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare […]

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes Accelerated approval in children aged eight to 17 years old recently diagnosed with stage 3 T1D to delay the decline in endogenous insulin production Approval based on the PROTECT phase 3 study and additional […]

Zodiac Partners II, LLC Reaffirms its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

West Palm Beach FL, June 12, 2026 (GLOBE NEWSWIRE) — In light of the recent announcement by Destination XL Group, Inc. (“DXLG” or “DXL”) that it has reevaluated its proposed merger with FBB Holdings, Inc., Zodiac Partners II, LLC today reaffirmed its previously announced $46 million all-cash tender offer to acquire all outstanding shares of […]

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

– JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved JAK inhibitors – – Selective JAK V617F inhibitor, CGT1145, on track for IND in 2026 – WALTHAM, Mass. and BOULDER, Colo., June 12, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for […]

Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses

SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) — Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced preclinical data for REX-8756, an oral, potent and selective STAT6 inhibitor, is being presented at two upcoming scientific congresses. At the European Association of Allergy and Clinical […]

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, […]

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, today announces that it has submitted its response package to questions received from its European Notified Body, GMED, following the successful completion of the Stage 1 and Stage 2 quality system and technical documentation assessments […]